ロード中...
Octadecyloxyethyl benzyl tenofovir: A novel tenofovir diester provides sustained intracellular levels of tenofovir diphosphate
Pre-exposure prophylaxis (PrEP) with topically or systemically administered antiretroviral agents can prevent acquisition of human immunodeficiency virus type 1 (HIV-1) infection. However, in clinical trials using tenofovir-containing agents, HIV-1 acquisition is reduced but not eliminated. Incomple...
保存先:
| 出版年: | Antiviral Res |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6927535/ https://ncbi.nlm.nih.gov/pubmed/31550449 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2019.104614 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|